Adocia will be delivering an oral presentation at EASD next September 18th – Barcelona, Spain

Adocia announces an oral presentation at the 55th European Association for the Study of Diabetes EASD congress, being held September 16-20, 2019 in Barcelona, Spain.

This Abstract will cover its ADO09 (pramlintide insulin) product:

  • Oral Presentation #109: ADO09, a co-formulation of the amylin-analog pramlintide and the A21G human insulin analog, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes

Presenting Author: Dr. Grégory Meiffren

Session: OP 19 Treating diabetes with peptides from the gut

Date and Time: Wednesday, September 18, 2019 2:30 PM – 4:00 PM CEST

Location: Joslin Hall